Obesity
- All
- News
- Videos
- Photos
- Web Stories
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Hack It, Don't Work Hard: Does The Craze Around Ozempic Indicate India's Future Drug Dependency Over Holistic Wellness?
GLP-1s were originally developed to manage diabetes by lowering blood sugar levels. However, the additional benefit of weight loss has gained more attention than their primary function of controlling
-
Cancer History In Family? What You Can Do To Reduce Risk
When multiple members of a family have had cancer especially at young ages or at the same site, it can signal inherited risk factors.
-
Popular Weight-Loss Drugs Like Wegovy Fail To Lower Obesity-Related Cancer Risks, Study Finds
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type 2 diabetes, overweight, or obesity. These studies involved a total of more than 94,000 participants.
-
2026 Needs A National Obesity Strategy: Doctor Explains Why Weight Is Now A Public Health Emergency
The rising obesity trend is seriously worrying and requires urgent, dedicated and consistent intervention on both micro and macro scales.
-
Weight Loss Drugs In India: The Rise Of GLP-1s In 2025
GLP-1 receptor agonists mimic the action of the glucagon-like peptide-1 hormone, which is involved in the regulation of appetite and insulin secretion. When administered, these medications stimulate insulin production.
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
Doctor Shares The Top Healthcare Challenges India Must Solve In 2026, Before The Costs Become Unmanageable
Dr Sabine Kapasi explains how India is entering a year where further delay in healthcare reforms and advances will widen existing gaps in care.
-
Ozempic, Type 2 Diabetes, Weight Loss Drug Launched In India. Check Price
Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming diabetes and obesity market expected to power industry growth this decade.
-
'Ozempic' For Cats: Vets Test Weight-Loss Drug On Overweight Felines
Modeled after Ozempic, the treatment offers hope for pet owners struggling to manage feline obesity and its related health risks.
-
Japan Has A Law To Fight Obesity. How It Works
Japan introduced the Metabo Law in 2008 to regulate obesity - the root cause of many health ailments, like high blood pressure and heart disease
-
Unqualified Practitioners, Self-Styled Dietitians Worsening India's Obesity Crisis: Science Minister
Unqualified practitioners and self-styled dietitians are worsening Indias obesity crisis with misinformation, said Union Minister of State for Science and Technology Jitendra Singh.
-
San Francisco Sues Oreo, Coca-Cola, KitKat In First-Ever Lawsuit Over Ultra-Processed Foods
The lawsuit links the rise of ultra-processed foods to increasing rates of obesity, diabetes and cancer.
-
"Medication Alone Won't Reverse Obesity": WHO Issues Guidelines On GLP-1 Drugs
The WHO guideline emphasises that medicines alone will not solve the problem.Addressing obesity requires a comprehensive approach.
-
Study Finds Low Blood Choline As Possible Factor In Obesity-Related Alzheimer's Risk
A study links low blood choline levels in obese young adults to liver dysfunction, insulin resistance, and markers associated with increased Alzheimer's risk.
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
Hack It, Don't Work Hard: Does The Craze Around Ozempic Indicate India's Future Drug Dependency Over Holistic Wellness?
GLP-1s were originally developed to manage diabetes by lowering blood sugar levels. However, the additional benefit of weight loss has gained more attention than their primary function of controlling
-
Cancer History In Family? What You Can Do To Reduce Risk
When multiple members of a family have had cancer especially at young ages or at the same site, it can signal inherited risk factors.
-
Popular Weight-Loss Drugs Like Wegovy Fail To Lower Obesity-Related Cancer Risks, Study Finds
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type 2 diabetes, overweight, or obesity. These studies involved a total of more than 94,000 participants.
-
2026 Needs A National Obesity Strategy: Doctor Explains Why Weight Is Now A Public Health Emergency
The rising obesity trend is seriously worrying and requires urgent, dedicated and consistent intervention on both micro and macro scales.
-
Weight Loss Drugs In India: The Rise Of GLP-1s In 2025
GLP-1 receptor agonists mimic the action of the glucagon-like peptide-1 hormone, which is involved in the regulation of appetite and insulin secretion. When administered, these medications stimulate insulin production.
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
Doctor Shares The Top Healthcare Challenges India Must Solve In 2026, Before The Costs Become Unmanageable
Dr Sabine Kapasi explains how India is entering a year where further delay in healthcare reforms and advances will widen existing gaps in care.
-
Ozempic, Type 2 Diabetes, Weight Loss Drug Launched In India. Check Price
Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming diabetes and obesity market expected to power industry growth this decade.
-
'Ozempic' For Cats: Vets Test Weight-Loss Drug On Overweight Felines
Modeled after Ozempic, the treatment offers hope for pet owners struggling to manage feline obesity and its related health risks.
-
Japan Has A Law To Fight Obesity. How It Works
Japan introduced the Metabo Law in 2008 to regulate obesity - the root cause of many health ailments, like high blood pressure and heart disease
-
Unqualified Practitioners, Self-Styled Dietitians Worsening India's Obesity Crisis: Science Minister
Unqualified practitioners and self-styled dietitians are worsening Indias obesity crisis with misinformation, said Union Minister of State for Science and Technology Jitendra Singh.
-
San Francisco Sues Oreo, Coca-Cola, KitKat In First-Ever Lawsuit Over Ultra-Processed Foods
The lawsuit links the rise of ultra-processed foods to increasing rates of obesity, diabetes and cancer.
-
"Medication Alone Won't Reverse Obesity": WHO Issues Guidelines On GLP-1 Drugs
The WHO guideline emphasises that medicines alone will not solve the problem.Addressing obesity requires a comprehensive approach.
-
Study Finds Low Blood Choline As Possible Factor In Obesity-Related Alzheimer's Risk
A study links low blood choline levels in obese young adults to liver dysfunction, insulin resistance, and markers associated with increased Alzheimer's risk.
